1 |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2 |
MORATH I, HARTMANN T N, ORIAN-ROUSSEAU V. CD44: More than a mere stem cell marker[J]. Int J Biochem Cell Biol, 2016, 81(Pt A): 166-173.
|
3 |
ROOSTA Y, SANAAT Z, NIKANFAR A R, et al. Predictive value of CD44 for prognosis in patients with breast cancer[J]. Asian Pac J Cancer Prev,2020,21(9): 2561-2567.
|
4 |
HU Y, ZHANG Y R, GAO J L,et al.The clinicopathological and prognostic value of CD44 expression in bladder cancer:a study based on meta-analysis and TCGA data[J]. Bioengineered,2020,11(1): 572-581.
|
5 |
LIU S, YAO X X, ZHANG D, et al. Analysis of transcription factor-related regulatory networks based on bioinformatics analysis and validation in hepatocellular carcinoma[J]. Biomed Res Int, 2018, 2018: 1431396.
|
6 |
ZHOU L, DU Y Y, KONG L Q, et al. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis[J]. Onco Targets Ther, 2018, 11: 1861-1869.
|
7 |
SUBRAMANIAN A, TAMAYO P, MOOTHA V K, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles[J]. Proc Natl Acad Sci USA, 2005, 102(43): 15545-15550.
|
8 |
KANEHISA M, GOTO S. KEGG: Kyoto encyclopedia of genes and genomes[J]. Nucleic Acids Res, 2000, 28(1): 27-30.
|
9 |
HARRIS M A, CLARK J, IRELAND A, et al. The Gene Ontology (GO) database and informatics resource[J]. Nucleic Acids Res, 2004, 32(Database issue): D258-D261.
|
10 |
SU G, MORRIS J H, DEMCHAK B, et al. Biological network exploration with Cytoscape 3[J]. Curr Protoc Bioinformatics,2014.DOI:10.1002/0471250953.bi0813s47 .
doi: 10.1002/0471250953.bi0813s47
|
11 |
SZKLARCZYK D, MORRIS J H, COOK H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible[J]. Nucleic Acids Res,2017,45(D1):D362-D368.
|
12 |
VACCARELLA S, FRANCESCHI S, BRAY F,et al. Worldwide thyroid-cancer epidemic? the increasing impact of overdiagnosis[J].N Engl J Med,2016,375(7): 614-617.
|
13 |
SAJI M, RINGEL M D. The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors[J]. Mol Cell Endocrinol, 2010, 321(1): 20-28.
|
14 |
RYU Y J, CHOE J Y, LEE K, et al. Clinical prognostic significance of cancer stem cell markers in patients with papillary thyroid carcinoma[J]. Oncol Lett, 2020, 19(1): 343-349.
|
15 |
YAN Y M, ZUO X S, WEI D Y. Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target[J]. Stem Cells Transl Med, 2015, 4(9): 1033-1043.
|
16 |
HASSN MESRATI M, SYAFRUDDIN S E, MOHTAR M A, et al. CD44: a multifunctional mediator of cancer progression[J]. Biomolecules, 2021, 11(12): 1850.
|
17 |
NAM K, OH S, LEE K M, et al. CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells[J]. Cell Signal, 2015, 27(9): 1882-1894.
|
18 |
WANG S J, BOURGUIGNON L Y W. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance[J].Am J Pathol,2011,178(3):956-963.
|
19 |
HAO J L, MADIGAN M C, KHATRI A, et al. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147[J].PLoS One,2012,7(8):e40716.
|
20 |
LI W M, JIA H, WANG J C, et al. A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer[J]. Oncotarget, 2017, 8(18): 30063-30076.
|
21 |
HE Y T, XUE C, YU Y, et al. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer[J]. Cancer Manag Res, 2018, 10: 3857-3865.
|
22 |
PUVANENTHIRAN S, ESSAPEN S, HAAGSMA B,et al. Co-expression and prognostic significance of the HER family members, EGFRvⅢ, c-MET, CD44 in patients with ovarian cancer[J].Oncotarget,2018,9(28): 19662-19674.
|
23 |
SAWANT S, AHIRE C, DONGRE H, et al. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma[J]. J Oral Pathol Med, 2018, 47(7): 665-673.
|
24 |
FIGGE J, DEL ROSARIO A D, GERASIMOV G,et al.Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma[J]. Exp Mol Pathol, 1994, 61(3): 203-211.
|
25 |
WOOD S L, PERNEMALM M, CROSBIE P A,et al. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets[J]. Cancer Treat Rev, 2014, 40(4): 558-566.
|
26 |
陈 顺, 王 俊. 胆管癌肿瘤微环境与免疫治疗[J].临床肝胆病杂志,2022,38(10):2428-2432.
|
27 |
NAJAFI M, HASHEMI GORADEL N, FARHOOD B,et al. Macrophage polarity in cancer: a review[J]. J Cell Biochem, 2019, 120(3): 2756-2765.
|
28 |
MORANA O, WOOD W, GREGORY C D. The apoptosis paradox in cancer[J]. Int J Mol Sci, 2022, 23(3): 1328.
|